By Devika Patel
Knoxville, Tenn., Dec. 18 - Neuralstem Inc. arranged a direct offering of stock for $2 million, according to a prospectus supplement filed Thursday with the Securities and Exchange Commission.
The company will sell 1.6 million shares at $1.25 apiece.
Midtown Partners & Co., LLC is the agent.
Proceeds will be used for general corporate purposes.
Based in Rockville, Md., Neuralstem develops technologies to transplant human neural stem cells.
| Issuer: | Neuralstem Inc.
|
| Issue: | Stock
|
| Amount: | $2 million
|
| Shares: | 1.6 million
|
| Price: | $1.25
|
| Warrants: | No
|
| Pricing date: | Dec. 18
|
| Agent: | Midtown Partners & Co., LLC
|
| Stock symbol: | Amex: CUR
|
| Stock price: | $2.18 at close Dec. 17
|
| Market capitalization: | $57.7 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
